Chronic Lymphocytic Leukemia — Trials

Chronic Lymphocytic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

1,256 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 265
Recruiting: 124
Ph III recruiting: 16
Growth YoY: −16.3%
Industry share: 33%
Top sponsor: City of Hope Medical Center
Termination share: 34.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (239)

clinicaltrialsPublishedShowing 401–450 of 579 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01163201	T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies	withdrawn	Phase 1 / Phase 2	0	Masonic Cancer Center, University of MinnesotaOTHER	1	Dec 2, 2017	clinicaltrials
NCT02132624	CD19-targeting 3rd Generation CAR T Cells for Refractory B Cell Malignancy - a Phase I/IIa Trial.	completed	Phase 1 / Phase 2	15	Uppsala UniversityOTHER	1	Oct 30, 2017	clinicaltrials